Evidence map›Paper›PMID 36268069›Full record

ArticleJournal of pathology informatics2022

MMO-Net (Multi-Magnification Organ Network): A use case for Organ Identification using Multiple Magnifications in Preclinical Pathology Studies.

Citlalli Gámez Serna, Fernando Romero-Palomo, Filippo Arcadu, Jürgen Funk, Vanessa Schumacher, Andrew Janowczyk

Open access · goldAbstract read
In one paragraph

Article in Journal of pathology informatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Deep Learning-based Modeling for Preclinical Drug Safety Assessment.bioRxiv : the preprint server for biology · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Citlalli Gámez SernaRoche Pharma Research and Early Development (pRED), Oncology, Roche Innovation Center Basel, Basel, Switzerland.
Fernando Romero-PalomoRoche Pharma Research and Early Development (pRED), Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.
Filippo ArcaduRoche Pharma Research and Early Development Informatics (pREDi), Safety Development Informatics, Roche Innovation Center Basel, Basel, Switzerland.
Jürgen FunkRoche Pharma Research and Early Development (pRED), Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.
Vanessa SchumacherRoche Pharma Research and Early Development (pRED), Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.
Andrew JanowczykDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.
Roche (Switzerland) · CHCase Western Reserve University · US

Funding

Computational Pathology of Proteinuric DiseasesR01DK118431 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI BARISONI, LAURA MARIACHIARA, HODGIN, JEFFREY BENTON · 2018 to 2025
$3.6M
RadxTools for assessing tumor treatment response on imagingU01CA248226 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI TIWARI, PALLAVI, VISWANATH, SATISH EASWAR · 2020 to 2022
$1.4M
HistoTools: A suite of digital pathology tools for quality control, annotation and dataset identificationU01CA239055 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI JANOWCZYK, ANDREW ROBERT, MADABHUSHI, ANANT · 2019 to 2022
$1.0M
NCI NIH HHS U01 CA239055NCI NIH HHS U01 CA248226NIDDK NIH HHS R01 DK118431
6 · The paper itself

Abstract

Identifying organs within histology images is a fundamental and non-trivial step in toxicological digital pathology workflows as multiple organs often appear on the same whole slide image (WSI). Previous works in automated tissue classification have investigated the use of single magnifications, and demonstrated limitations when attempting to identify small and contiguous organs at low magnifications. In order to overcome these shortcomings, we present a multi-magnification convolutional neural network (CNN), called MMO-Net, which employs context and cellular detail from different magnifications to facilitate the recognition of complex organs. Across N=320 WSI from 3 contract research organization (CRO) laboratories, we demonstrate state-of-the-art organ detection and segmentation performance of 7 rat organs with and without lesions: liver, kidney, thyroid gland, parathyroid gland, urinary bladder, salivary gland, and mandibular lymph node (AUROC=0.99-1.0 for all organs, Dice≥0.9 except parathyroid (0.73)). Evaluation takes place at both inter- and intra CRO levels, suggesting strong generalizability performance. Results are qualitatively reviewed using visualization masks to ensure separation of organs in close proximity (e.g., thyroid vs parathyroid glands). MMO-Net thus offers organ localization that serves as a potential quality control tool to validate WSI metadata and as a preprocessing step for subsequent organ-specific artificial intelligence (AI) use cases. To facilitate research in this area, all associated WSI and metadata used for this study are being made freely available, forming a first of its kind dataset for public use.

Indexed as

Convolutional neural networksDigital pathologyMultiple magnificationsOrgan identificationPreclinical assessmentQuality control

Identifiers

PMID36268069
PMCPMC9577048
OpenAlexW4285810183

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.